BRIEF-Vertex sells Incivo product royalty rights for $152 mln

Nov 20 (Reuters) - Vertex Pharmaceuticals Inc : * Sells incivo  product royalty rights for $152 million * Says Vertex to receive $152 million cash payment from janssen in 2013 * Says will no longer receive royalties on incivo sales beginning in 2014 * Increases 2013 year-end guidance for cash, cash equivalents and marketable
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.